SARS-CoV-2: Clinical Trials

3 trials for SARS-CoV-2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 3

Follow SARS-CoV-2: new trials by email Literature Review of SARS-CoV-2 trials Research Report on SARS-CoV-2

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Efficacy of Pre-procedural Mouth Rinses on COVID-19 Saliva Viral Load
Distilled Water, 1% Povidone Iodine (PVP-I), 1.5% Hydrogen Peroxide (H2O2) - SARS-CoV-2, COVID-19
Phase 4CompletedKing Abdulaziz University902021-01-032022-07-21
FREEDOM COVID-19 Anticoagulation Strategy
Enoxaparin, Apixaban - COVID-19, SARS-CoV-2
Phase 4CompletedValentin Fuster34602020-09-082023-03-16
Stopping ACE-inhibitors in COVID-19
ACE inhibitor, angiotensin receptor blocker - SARS-CoV-2, COVID-19
Phase 4CompletedMedical University Innsbruck2162020-04-202022-09-13

Narrower conditions

COVID-19 (3)  ·  Coronavirus Infections (1)  ·  Pathologic Complete Response (1)

Broader conditions

Coronaviridae Infections (3)  ·  Infections (3)  ·  Lung Diseases (3)  ·  Nidovirales Infections (3)  ·  Pneumonia (3)  ·  Pneumonia, Viral (3)  ·  RNA Virus Infections (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Infections (3)  ·  Virus Diseases (3)  ·  Coronavirus Infections (2)  ·  Disease Attributes (1)  ·  Disease Progression (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Angiotensin Receptor Antagonists (1)  ·  Angiotensin-Converting Enzyme Inhibitors (1)  ·  Cetylpyridinium (1)  ·  Enoxaparin (1)  ·  Hydrogen Peroxide (1)  ·  Mouthwashes (1)  ·  Povidone-Iodine (1)  ·  Sodium Hypochlorite (1)  ·  Water (1)  ·  apixaban (1)  ·  hydrated silica gel-based toothpaste (1)

Sponsors

King Abdulaziz University (1)  ·  Medical University Innsbruck (1)  ·  Valentin Fuster (1)

Countries

Austria (1)  ·  Brazil (1)  ·  Colombia (1)  ·  Germany (1)  ·  India (1)  ·  Mexico (1)  ·  Saudi Arabia (1)  ·  United States (1)

Top investigators

Anu Lala, MD (1)  ·  Valentin Fuster, MD,PhD (1)

Results publications

PMID 11225528, PMID 11505791, PMID 16490989, PMID 17099299, PMID 20354090, PMID 23017003, PMID 23433693, PMID 29633177, PMID 30639191, PMID 31761015, PMID 32047895, PMID 32159775, PMID 32326426, PMID 32425001, PMID 32505069, PMID 32859459, PMID 33215159, PMID 34126053, PMID 35241226, PMID 36889611